OrganiGram (CVE:OGI) had its price target raised by Cormark from C$8.50 to C$10.50 in a report released on Wednesday, BayStreet.CA reports. Cormark currently has a speculative buy rating on the stock.

Several other research firms have also commented on OGI. Jefferies Financial Group set a C$10.00 price target on shares of OrganiGram and gave the company a buy rating in a report on Monday, February 25th. Pi Financial lifted their price target on shares of OrganiGram from C$8.00 to C$10.00 in a report on Tuesday, January 29th. Finally, Canaccord Genuity lifted their price target on shares of OrganiGram from C$6.00 to C$7.50 and gave the company an average rating in a report on Wednesday, December 19th.

CVE OGI opened at C$8.90 on Wednesday. OrganiGram has a one year low of C$3.78 and a one year high of C$10.03. The company has a quick ratio of 7.00, a current ratio of 14.53 and a debt-to-equity ratio of 42.38. The stock has a market capitalization of $1.24 billion and a PE ratio of 23.99.

OrganiGram (CVE:OGI) last posted its quarterly earnings results on Monday, April 15th. The company reported C($0.05) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of C$0.04 by C($0.09). The firm had revenue of C$26.93 million for the quarter, compared to analyst estimates of C$26.27 million. Equities analysts forecast that OrganiGram will post 0.380862631863442 EPS for the current year.

OrganiGram Company Profile

OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.

Featured Article: Why is the Consumer Price Index (CPI) important?

Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.